Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - macrogolum 3350, natrii chloridum, natrii hydrogenocarbonas, kalii chloridum - polvere per soluzione orale - macrogolum 3350 13.125 g, natrii chloridum 350.7 mg, natrii hydrogenocarbonas 178.5 mg, kalii chloridum il 46,6 mg, saccharinum natricum, sono, per la polvere di carta. - stitichezza, koprostase - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 18 mg, zucchero sfere corrisp. sintetico 10.9 mg, hypromellosum, talco, acido hydrochloridum, ethylcellulosum, hydroxypropylcellulosum, triethylis citras, hypromellosi acetas succinas, carmellosum natricum corrisp. sodio 3.87 mg, cellulosum microcristallinum, magnesio stearas, silice colloidalis anhydrica, Überzug: poli(alcole vinylicus), talco, macrogolum 3350, e 171, e 172 (giallo), acido hydrochloridum, per compresso haze. - centrale efficiente ad azione prolungata - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 27 mg, zucchero sfere corrisp. sintetico 16.36 mg, hypromellosum, talco, acido hydrochloridum, ethylcellulosum, hydroxypropylcellulosum, triethylis citras, hypromellosi acetas succinas, carmellosum natricum corrisp. sodio 5.78 mg, cellulosum microcristallinum, magnesio stearas, silice colloidalis anhydrica, Überzug: poli(alcole vinylicus), talco, macrogolum 3350, e 172 (giallo), acido hydrochloridum, per compresso haze. - centrale efficiente ad azione prolungata - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 36 mg, zucchero sfere corrisp. la biomassa 21.8 mg, hypromellosum, talco, acido hydrochloridum, ethylcellulosum, hydroxypropylcellulosum, triethylis citras, hypromellosi acetas succinas, carmellosum natricum corrisp. sodio 7.71 mg, cellulosum microcristallinum, magnesio stearas, silice colloidalis anhydrica, Überzug: poli(alcole vinylicus), talco, macrogolum 3350, e 171, acido hydrochloridum, per compresso haze. - centrale efficiente ad azione prolungata - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 54 mg, zucchero sfere corrisp. la biomassa 32.7 mg, hypromellosum, talco, acido hydrochloridum, ethylcellulosum, hydroxypropylcellulosum, triethylis citras, hypromellosi acetas succinas, carmellosum natricum corrisp. sodio 11.57 mg, cellulosum microcristallinum, magnesio stearas, silice colloidalis anhydrica, Überzug: poli(alcole vinylicus), talco, macrogolum 3350, e 171, e 172 (rosso), acido hydrochloridum, per compresso haze. - centrale efficiente ad azione prolungata - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - methylphenidati hydrochloridum - depocaps - methylphenidati hydrochloridum 10 mg, excipiens pro capsula. - psychotonikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - methylphenidati hydrochloridum - depocaps - methylphenidati hydrochloridum 20 mg, excipiens pro capsula. - psychotonikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - methylphenidati hydrochloridum - depocaps - methylphenidati hydrochloridum 30 mg, excipiens pro capsula. - psychotonikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - methylphenidati hydrochloridum - depocaps - methylphenidati hydrochloridum 40 mg, excipiens pro capsula. - psychotonikum - synthetika

Unione Europea - italiano - EMA (European Medicines Agency)

stada arzneimittel ag - budesonide, micronised - glomerulonephritis, iga - antidiarrheals, intestinali antiinfiammatori / antinfettivo agenti - kinpeygo is indicated for the treatment of primary immunoglobulin a (iga) nephropathy (igan) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (upcr) ≥1. 5 g/gram.